L-RNA Aptamer Enhances Glioblastoma Therapy in GLORIA Trial
In an unprecedented advancement in glioblastoma treatment, a groundbreaking phase I/II clinical trial known as GLORIA has unveiled promising results combining L-RNA aptamer-based CXCL12 inhibition...
















